Home/Filings/4/0001209191-23-010651
4//SEC Filing

Sims Andrew John Hugh MacIntyre 4

Accession 0001209191-23-010651

CIK 0001095981other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:32 PM ET

Size

5.5 KB

Accession

0001209191-23-010651

Insider Transaction Report

Form 4
Period: 2023-02-15
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-15+104,404104,404 total
    Exercise: $0.39Exp: 2033-02-15Common Stock (104,404 underlying)
Footnotes (1)
  • [F1]The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001802687

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:32 PM ET
Size
5.5 KB